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To explore the interdomain co-operativity during hu-
man plasminogen (HPG) activation by streptokinase
(SK), we expressed the cDNAs corresponding to each SK
domain individually (, , and ), and also their two-
domain combinations, viz.  and  in Escherichia coli.
After purification,  and  showed activator activities of
approximately 0.4 and 0.05%, respectively, as compared
with that of native SK, measured in the presence of
human plasmin, but the bi-domain constructs  and 
showed much higher co-factor activities (3.5 and 0.7%
of native SK, respectively). Resonant Mirror-based bind-
ing studies showed that the single-domain constructs
had significantly lower affinities for “partner” HPG,
whereas the affinities of the two-domain constructs
were remarkably native-like with regards to both bina-
ry-mode as well as ternary mode (“substrate”) binding
with HPG, suggesting that the vast difference in co-
factor activity between the two- and three-domain struc-
tures did not arise merely from affinity differences be-
tween activator species and HPG. Remarkably, when
the co-factor activities of the various constructs were
measured with microplasminogen, the nearly 50-fold
difference in the co-factor activity between the two- and
three-domain SK constructs observed with full-length
HPG as substrate was found to be dramatically attenu-
ated, with all three types of constructs now exhibiting a
low activity of approximately 1–2% compared to that of
SKHPN and HPG. Thus, the docking of substrate
through the catalytic domain at the active site of SK-
plasmin(ogen) is capable of engendering, at best, only a
minimal level of co-factor activity in SKHPN. Therefore,
apart from conferring additional substrate affinity
through kringle-mediated interactions, reported earlier
(Dhar et al., 2002; J. Biol. Chem. 277, 13257), selective
interactions between all three domains of SK and the
kringle domains of substrate vastly accelerate the plas-
minogen activation reaction to near native levels.
Streptokinase (SK)1 is a widely used bacterial thrombolytic
protein that is secreted by several species of -hemolytic strep-
tococci (1, 2). It consists of a single polypeptide chain of 414
residues and is organized into three structurally similar, inde-
pendently folding domains (termed , , and  in order from N
to C terminus of the polypeptide) that are separated by coiled
coils and small flexible regions at the two ends (3–5). Like
several other well known thrombolytic proteins, such as uroki-
nase and tissue-plasminogen activator, SK exerts its effects
through the conversion of human plasminogen (HPG) to its
proteolytically active form, plasmin (HPN). Thus, during the
treatment of various circulatory disorders, e.g. myocardial in-
farction, deep vein thrombosis, pulmonary embolism, etc., HPN
generated by the activation of HPG helps restore blood flow to
the afflicted part by proteolytic dissolution of the fibrin in the
pathological clot. In contrast to tissue-plasminogen activator
and urokinase, which are intrinsically HPG-specific proteases
and thus “directly” act on HPG, SK is an enzymatically inert
protein (6). However, it recruits circulating HPG to generate
HPG activating potential; SK first combines with “partner”
HPG in an equimolar manner to form a tight, enzymatically
active complex, the so-called SKHPG “virgin” activator com-
plex (7, 8), which rapidly converts into a SKHPN complex. The
mature SKHPN activator complex then catalytically trans-
forms “substrate” molecules of HPG to HPN (1).
Plasmin is essentially a protease with a trypsin-like side
chain specificity and broad substrate specificity. Free HPN
cannot activate substrate HPG to HPN, but once combined
with SK, the hitherto “nonspecific” active site of HPN becomes
inordinately specific for the cleavage of the Arg561-Val562 scis-
sile peptide bond in substrate HPG (9). This remarkable alter-
ation of the macromolecular substrate specificity of HPN by SK
as a result of the latter’s “protein co-factor” property, which has
been a subject of intense investigations, is currently thought to
be due to exosites generated on the SKHPN activator complex,
as demonstrated recently by the elegant use of active site-
labeled fluorescent HPN derivatives (10). Deciphering the mo-
lecular details of the mechanism and associated structure-
function co-relations whereby SK modulates the substrate
preference of the active site of plasmin(ogen) after complex-
ation with the latter is undoubtedly vital to the successful
design of improved SK-based thrombolytic proteins of the fu-
ture (11, 12). However, the fact that both participants are
complex, multi-domain proteins: SK, with its three structurally
homologous domains (3–5), and HPG, composed of a catalytic
and five kringle domains (1, 13), greatly compounds the struc-
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ture-function challenges involved in solving this question. The
crystal structure of SK complexed with microplasmin (the cat-
alytic protease domain of HPN, devoid of its five kringle do-
mains) has provided insights regarding the molecular mecha-
nism whereby SK manages to switch the substrate specificity of
the active site of HPN (5), indications of which had also been
gleaned earlier through solution studies (14, 15). These studies
indicate that SK acts as a protein co-factor of the plasmin
active site by forming a “three-sided valley” around the active
center by virtue of its tri-domain structure. Thus, it has been
postulated that the docking of the catalytic subunit of HPG
onto the activator complex by protein-protein interactions fa-
cilitates cleavage of the scissile peptide bond in the macromo-
lecular substrate by an otherwise nonspecific active site (5).
However, the crystal structure does not provide any indication
of whether the kringle domains of the substrate play any role in
this process.
In contrast to the three-domain structure of SK, staphyloki-
nase (SAK), another functionally similar, “indirect” HPG acti-
vator protein but one that has a single domain only, also
operates by docking substrate HPG into the active center of its
binary complex with plasmin(ogen) (16). Although SAK dis-
plays little sequence similarity with SK, its single domain
bears a remarkable conformational similarity with one of the
three SK domains in particular (the  domain) and all three
domains of SK in general, which, in turn, are structurally
homologous to each other (17). However, the SAKHPN activa-
tor complex is known to possess a significantly lower catalytic
efficiency than SKHPN (18, 19). Apart from the single-domain
prototypic structure of SAK, another mechanistically similar
plasminogen activator from Streptococcus uberis (abbreviated
SUPA) has also been isolated that possesses a two-domain
structural motif (20, 21). Thus, a compelling need exists to
glean insights regarding the similarities and dissimilarities in
the “design principles” between the three-domain SK, on the
one hand, and the single- and two-domain structures of SAK
and SUPA on the other, particularly in terms of the structure-
function co-relations that underlie the interdomain co-operat-
ivity between the individual SK domains.
Taking a minimalist approach, a pertinent question that can
be posed in the above context is whether any of the isolated
domains of SK also possess, like the single domain of SAK, the
ability to bind with HPG in both substrate and partner modes
and, if the answer is affirmative, whether this binding is func-
tionally translated into a capability, even if highly compro-
mised compared with native SK, to switch the nonspecific sub-
strate preference of partner plasmin to that of a HPG activator
enzyme. A recent study (22) has attempted to address this
issue, particularly in terms of the functional properties of sin-
gle SK domains, and elegantly demonstrated the presence of
detectable, albeit very low levels of HPG activator activity in
two of the three SK domains. The results of this study also
stimulate curiosity about the possibility of a hierarchical gen-
eration of catalytic activity in SK (i.e. the possible existence of
a progressive increase in co-factor activity from the single- to
two-domain, and finally, to the three-domain native motif) and
the need to gain meaningful insights into the design princi-
ple(s) selected by evolution for plasminogen activators of bac-
terial origin. As a first step in this direction, in the present
study we have therefore expressed each of the three domains of
SK, as well as their two-domain combinations (viz.  and )
in a heterologous expression system and compared their cata-
lytic and binding properties both against full-length macromo-
lecular substrate, HPG as well as its kringle-less derivative,
microplasminogen (PG). Thus, with this approach, we have
attempted to explore the interdomain co-operation prevalent in
SK, as well as between the SKHPG activator complex and
substrate HPG. The results presented below reveal that the
kringle domains of substrate help not only in substrate dock-
ing, as proposed recently (23, 24), but also in substrate turn-
over, even though they are distinctly apart from the immediate
microenvironment of the “target” scissile peptide bond, the
specific region of the substrate polypeptide that is selectively
cleaved during plasminogen activation.
EXPERIMENTAL PROCEDURES
Materials
HPG was either purchased from Roche Applied Science or purified
from human plasma by affinity chromatography (25). The cloning vec-
tor pBluescript II KS, thermostable DNA polymerase (Pfu) and Esch-
erichia coli strain XL-Blue were procured from Stratagene Inc. (La
Jolla, CA). All other enzymes used for genetic manipulation were ob-
tained from New England Biolabs (Beverly, MA). The oligonucleotide
primers were either synthesized in-house on an Applied Biosystems
DNA synthesizer model 492 or custom-synthesized by Ransom Hill
Biosciences Inc. (Ramona, CA). DEAE-Sepharose (Fast-flow) and Che-
lating Sepharose were procured from Amersham Biosciences, and
phenyl-agarose for hydrophobic interaction chromatography was pur-
chased from Affinity Chromatography Ltd. The T7 RNA polymerase
promoter-based expression vector, pET-23d and Bug buster® (a com-
mercial reagent for rapid bacterial cell lysis) were procured from No-
vagen Inc. (Madison, WI). All other chemicals used were of the best
commercial grade available.
Expression and Purification of SK from E. coli
The plasmid construct for the intracellular expression of SK in E. coli
(pET-23d-SK) under the control of the T7 phage RNA polymerase pro-
moter has been described (26). Briefly, the purification involved lyzing
the cells by sonication followed by ammonium sulfate precipitation
(60% saturation) and two chromatographic steps, viz. hydrophobic in-
teraction chromatography on phenyl-agarose and anion exchange chro-
matography. This yielded homogeneous SK with an overall yield of
55–60% with a specific activity of 1.1  105 IU/mg protein (27).
Cloning of Single and Bi-domains of SK
The exact boundaries of individual domains were selected based on
limited proteolysis data (4), which also cross-correlated well with the
limits defined by the crystal structure of SK (5). The sequences 1–143
and 143–293 were chosen to represent the  domain and the  domain,
respectively (4). The  domain (SK293–414) was cloned from the region
coding for residues 300–387, because the C-terminal end of the 
domain (residues 388–414) contains residues that are not critical for
the functioning of full-length SK and forms a disorganized and flexible
segment that undergoes rapid degradation in the presence of HPN (4, 5,
28, 29).
The construction of the truncated derivatives of SK was carried out
by PCR amplification of the desired sequence, using SK as template,
and specific upstream and downstream primers that also contained
specific restriction endonuclease (RE) sites to allow for facile, direc-
tional docking of the amplified fragment into pET-23d-SK. Primers for
the construction of the  domain were as follows: upstream primer,
5-AGCCAATTAGACGTCAGCGTTGCAGAAACTGTTGAGG-3, and
downstream primer, 5-ATCTTGCTCGAGAACGCGCACATGTCCACT-
TAGCAA-3. Primers for the construction of the  domain were as
follows: upstream primer, 5-TCAGCCATGGTTAGACCATATAAA-3,
and downstream primer, 5-ATGGGGATCCTATTTCAAGTGACTGCG-
ATCAAAGGG-3. Primers for the construction of the  domain were as
follows: upstream primer, 5-ATACCATGGTTGATGTCGATACTAAT-
GAA-3, and downstream primer, 5-TTGCTCGAGGGCTAAATGATA-
GCTGGCATTCTC-3. Construct  was prepared as follows: The “vec-
tor” DNA fragment obtained after digestion of pET-23d- with the REs
BglII and BseRI was ligated with the “insert” fragment obtained from
the digestion of pET-23d-SK with the same REs. Primers for the con-
struction of  were as follows: upstream primer, 5-TCAGCCATGG-
TTAGACCATATAAA-3, and downstream primer, 5-ATAGGCTAAAT-
GATAGCTAGCATTCTCTCCTTC-3.
Purification of His6-tagged  and  Domains
Using Metal Affinity Chromatography
The single-domain constructs,  as well as , were expressed as
proteins with His6 tag extensions at their C termini to aid their puri-
fication by affinity chromatography on Ni2-immobilized metal affinity
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chromatography (30). The  domain was found predominantly in the
form of inclusion bodies, whereas the  domain remained soluble in the
intracellular milieu of E. coli. Hence, inclusion bodies of the  domain
obtained after lyses of the cells with Bug buster reagent were first
dissolved in 8 M urea. The inclusion bodies of the  domain dissolved in
8 M urea and the soluble  domain obtained after cell lysis were further
diluted 15-fold in 50 mM sodium phosphate buffer (pH 7.5) containing
10 mM imidazole and 250 mM NaCl before loading on the immobilized
metal affinity chromatography matrices. Successive washes with 50 mM
sodium phosphate buffer (pH 7.5) containing 60 mM imidazole and 250
mM NaCl were given to remove unwanted, loosely bound proteins, and
the His-tagged proteins were finally eluted with 50 mM sodium phos-
phate buffer (pH 7.5) containing 250 mM imidazole and 250 mM NaCl.
Purification of  Domain of SK
The  domain of SK (residues 143–293) was expressed in E. coli as a
soluble protein at a level 30% of the total soluble protein fraction and
was purified as described earlier (23).
Purification of the Two-domain Constructs  (SK 1–293)
and  (SK 143–414)
The covalently contiguous two-domain construct, , was expressed
as a soluble protein in E. coli BL-21 cells, whereas the  protein was
expressed predominantly as inclusion bodies. The purification involved
lyzing the cells by sonication followed by ammonium sulfate precipita-
tion (60% saturation) and two tandem chromatographic steps, namely
hydrophobic ion chromatography on phenyl-agarose and ion exchange
chromatography on DEAE-Sepharose (Fast-flow) essentially as de-
scribed for SK above. The eluted fractions contained protein that was
more than 95% pure as analyzed by SDS-PAGE.
Circular Dichroic Analysis of nSK/SK Domains
Far-UV CD spectra of SK/SK domains (concentration 0.15 mg/ml in
phosphate-buffered saline, pH 7.2) were recorded on a Jasco-720 spec-
tropolarimeter. Measurements were carried out from 190 to 250 nm in
a 0.1-cm-pathlength cuvette, and the appropriate buffer base line was
subtracted from the protein spectra. The final spectrum analyzed was
an average of 10 scans. Secondary structure analysis to compute the
content of  helix,  sheet, random coil, and other secondary struc-
ture(s) were carried out using the algorithm described by Yang et al.
(31).
Preparation of Microplasminogen
Microplasminogen, the catalytic domain of plasminogen (residues
Lys539–Asn790), devoid of all the kringles was prepared by cleavage of
HPG by HPN under alkaline conditions (0.1 N glycine/NaOH buffer, pH
10.5, 10:1 ratio of HPG and HPN) at 30 °C. Microplasminogen was
purified from the reaction mixture by passing through a Lys-Sepharose
column (Amersham Biosciences), followed by a Soyabean-trypsin inhib-
itor-Sepharose CL-4B column to absorb HPN and microplasmin, as
reported (23, 32). The flow-through was then subjected to molecular
sieve chromatography, after concentration by ultrafiltration, on a col-
umn (16  60 cm) of Superdex-75TM (Amersham Biosciences). The
purity of PG formed was analyzed by SDS-PAGE, which showed a
single band moving at the position expected from its molecular size (32),
and the identity of the protein was confirmed by N-terminal protein
sequencing. Activation with urokinase, which is known to be an effi-
cient activator of PG despite the absence of kringle domains in the
latter, was used to establish that the rate of activation of this prepara-
tion, when used as substrate, was comparable with that obtained when
using SKHPN as the activator species.
Assay for Detection of Extremely Low HPG Activation Capability
Catalytic amounts of domains were added to the assay buffer (100
mM Hepes, pH 7.5) containing 2 M of HPG and chromogenic substrate
(0.5 mM), and the change in absorbance was monitored spectrophoto-
metrically at 405 nm as a function of time at 22 °C (Pathway I). To
detect intrinsically low HPG activation capability in single-domain/bi-
domain construct(s) that may otherwise not be capable of activating the
partner HPG unless provided with a preformed active site (i.e. only
Pathway II capability), equimolar complexes of HPN and the SK deriv-
ative were premixed on ice for 1 min, and catalytic amounts were
withdrawn and added to 2 M HPG and chromogenic peptide substrate
in the assay buffer containing 100 mM Hepes (pH 7.5) in case of single-
domain proteins and 50 mM Tris-Cl (pH 7.5) in case of the two-domain
proteins. The reactions were recorded spectrophotometrically at 405
nm, and the progress curves obtained from corresponding control reac-
tions (containing HPG and same amounts of HPN but no domain) were
subtracted from the test reactions. The resultant curves so obtained
were used to determine the rate of HPG activation, which was then
expressed as a percentage of activity, relative to SK. The initial phase
(0–8 min) was generally used for this calculation in both cases, to
overcome any loss of activity at later stages caused by possible proteo-
lytic stability.
To establish whether the isolated domains had genuine activator
activities over and above that associated with the background cells,
E. coli BL21 cultures transformed with the pET-23d vector but not
containing any domain-encoding insert, after induction with isopropyl-
1-thio--D-galactopyranoside, were harvested and lyzed similarly to
ones prepared for purifying the individual domain(s). These cell lysates
were subjected to exactly the same treatments as the ones prepared
from cultures harboring plasmids for , , or , including immobilized
metal affinity chromatography and desalting steps. The fractions from
“control” columns (on which the lysates containing just the expression
plasmids without any SK domain insert were processed) identical in
volume to the corresponding eluted protein fractions from the “test”
columns (from which the domains were being purified) were collected in
parallel and were then used for assessing HPG activator activity. The
control fractions, which served to measure the background E. coli cell-
associated HPG activator activity consistently, showed a very low level
of activity (0.005%) but one that was significantly lower than the
activity observed with any of the truncated domain constructs.
Determination of Kinetic Constants for HPG Activator Activity
Varying amounts of HPG were added to the assay cuvette containing
fixed amounts of single-domain or bi-domain constructs and chromo-
genic substrate (0.5 mM), and the change in absorbance was monitored
at 405 nm as a function of time at 22 °C. Also, the kinetics of HPG
activation by the activator complexes were measured by transferring
suitable aliquots of preformed complexes (single-domain or bi-domain
constructs, and HPN) to the assay cuvette containing different concen-
trations of substrate HPG. To compute the kcat, the number of func-
tional HPN active sites was determined by titration with an active site
acylating reagent, p-nitrophenyl p-guanidinobenzoate (7, 33, 34).
Kinetic Analysis of Protein-Protein Interactions
Using Resonant Mirror Technology
Binary Interaction Analysis—Association and dissociation between
HPG and the nSK/SK domains, viz. bi-domains ( and ) and single-
domains ( and ) referred to hereafter as binary interaction, were
followed in real time by Resonant Mirror-based detection using IAsys
PlusTM system (Cambridge, UK) (35, 36). In these experiments, strepta-
vidin was captured on biotin cuvettes. This was followed by the attach-
ment of biotinylated HPG to the streptavidin captured on the cuvette.
Nonspecifically bound HPG was then removed by repeated washing
with phosphate-buffered saline followed by three washes with 10 mM
HCl. The net response chosen for the immobilized biotinylated HPG
onto the cuvette was 700–800 arc seconds in all the experiments. The
experiments were performed at 25 °C in 50 mM phosphate-buffered
saline (pH 7.4) containing 0.1% Tween 20, 250 mM NaCl, and 50 M
p-nitrophenyl p-guanidinobenzoate (binding buffer). The latter was in-
cluded to prevent plasmin-mediated proteolysis.
After equilibrating the cuvette with binding buffer, varying concen-
trations of either nSK/SK domains were added, and each binding re-
sponse was monitored during the “association” phase. Subsequently,
the cuvette was washed with the binding buffer, and the “dissociation”
phase was recorded (37). Following each cycle of analysis, the cuvette
was regenerated by washing with 10 mM HCl, and the base line was
re-established with the binding buffer. In parallel, in the control cell in
the dual channel cuvette, immobilized streptavidin alone was taken as
a negative control for the binding studies.
The data were analyzed after subtraction of the corresponding non-
specific refractive index component(s), and the kinetic constants were
calculated from the sensorgrams by nonlinear fittings of association
and dissociation curves using the software FASTfitTM, supplied by the
manufacturer. The dissociation rate constant (kd) was calculated from
the average of four dissociation curves obtained at saturating concen-
tration of ligate. The equilibrium dissociation constant (KD) was then
calculated from the extent of association of monophasic curve. The ka
was calculated from the equation kd/KD. The values of KD obtained
using this relationship were in good approximation to those obtained by
kd/ka obtained from the linear fit of kon versus ligate concentration (38).
Ternary Interaction Analyses—A Resonant Mirror technology-based
biosensor was also used to measure the rate and equilibrium dissocia-
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tion constants describing interactions between soluble ligates (HPG
and PG) and nSK/SK domains complexed with immobilized HPG. In
binary interaction studies, it was evident that when the soluble nSK/SK
domain was added to the immobilized HPG, a rapid and avid nSK/SK
domainsHPG (except single domains,  and ) binary complex forma-
tion occurs. The dissociation of these binary complexes is very slow
because of the high stability of SKHPG complex (23). After allowing the
complex to dissociate maximally (20 min), the dissociation base line
becomes stable, which remains unaffected even after washing with 2.5
mM EACA. In case of single domains ( and ), weak binary complex-
ation with immobilized HPG was observed, and it was seen that the
dissociation rates in binding buffer itself were very high; thus, stable
base lines as observed in the case of bi-domains and nSK were not
observed.
Varying concentrations of either “ternary” HPG (0.1–1.0 M) or PG
(1–6 M) were then added to monitor the binding by recording the
association phase. Subsequently, the cuvette was washed with the
binding buffer three times, and the dissociation phase was then re-
corded. After each cycle of analysis, the original base line was re-
established by stripping off the undissociated ternary ligate with 2.5
mM EACA followed by three washes with binding buffer. It was earlier
established (23) that EACA at this concentration completely abolishes
the interaction of ternary HPG with the binary complex, whereas the
binary complex remains stable. In experiments where PG was used as
the soluble ternary ligate, 1 mM EACA was found to be sufficient to strip
off the undissociated PG, whereas washing with binding buffer alone
resulted in incomplete regeneration of the base line (23). Equilibrium
dissociation constant(s) were determined by analysis of the extent of
association as well as from kd/ka. Dissociation and association constants
were calculated by the procedure similar to the one followed in case of
binary interaction analysis.
RESULTS AND DISCUSSION
Isolation and Characterization of Isolated Single and Bi-
domains of SK—To measure the HPG activator activities in
isolated domains and bi-domains of SK of Streptococcus equi-
similis, each of the three isolated domains (, SK1–143; ,
SK143–293; and , SK300–387) and bi-domain constructs (
and ) were constructed by PCR amplification of cDNAs en-
coding for respective domains followed by cloning in pET-23d, a
T7 phage RNA polymerase promoter-based vector (26). All of
these constructs were then expressed in E. coli BL21 (DE3)
cells. Good expression levels were observed for all of these
constructs, and purification strategies for each of them were
then standardized (see “Experimental Procedures”) to obtain
preparations with purity levels well over 95% as judged by
SDS-PAGE (Fig. 1A). The secondary structure content of the
isolated single- and double-domain derivatives was determined
using far-UV CD measurements (Fig. 1B). The secondary struc-
tural features of the SK derivatives indicated that they were
folded, because they were found to be largely in concordance
with the reported data in literature, either based on spectro-
scopic analysis (4, 28) or that expected from direct x-ray struc-
tural data on SK domains (5, 39, 40).
Substrate HPG activation by SK can proceed along two Path-
ways (41). The first is Pathway I, wherein, after a high affinity
complexation occurs between SK and partner HPG molecule, a
virgin site is formed in the zymogen in absence of any proteo-
lytic cleavage (7, 8). However, this complex rapidly converts to
SKHPN, the activator species that catalytically activates mol-
ecules of substrate HPG, after the partner HPG has been
proteolytically converted to plasmin. In Pathway II, SK can
directly complex with active HPN and then can activate sub-
strate HPG. Mutants of SK that are impaired in Pathway I
capability can sometimes activate substrate HPG through
pathway II if “supplied” with a preformed, partner active site in
the form of HPN (22). Thus, zymogen activation of partner
HPG by SK under Pathway I and the conversion of macromo-
lecular substrate specificity of the HPN active site upon the
latter’s complexation with SK constitute two distinct (although
partially overlapping) biochemical properties of HPG activa-
tion with this activator protein.
We first examined the functional ability of purified individ-
ual (single) domains to activate substrate HPG using either
excess HPG (Pathway I) or with excess substrate HPG after
premixing with equimolar amounts of HPN (Pathway II). The
-domain did not show any detectable activator/co-factor activ-
ity under either of these assay conditions, but in the case of 
and  domains, apparent activator activities that could be
FIG. 1. A, SDS-PAGE analysis of purified SK/SK domains. Purified
proteins were electrophoresed on 15% SDS-PAGE gels and stained with
Coomassie Blue R-250 dye. Lane 1, molecular mass markers (from top
to bottom, 97, 66, 45, 31, 21.5, and 14 kDa); lane 2,  domain; lane 3, 
domain; lane 4,  domain; lane 5,  domain; lane 6, nSK. B, far-UV
CD spectra of SK domains. The far-UV CD spectra in the wavelength
range of 197–250 nm was determined as outlined under “Experimental
Procedures.” The curves shown are nSK (i),  (solid line) and 
(dotted line) (ii), and  (dotted line) and  domains (solid line) (iii).
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detected using HPG alone were not more than 0.002% as com-
pared with the corresponding activity with SK, taken as 100%.
These results are very similar to those reported by Loy et al.
(22). However, the barely perceptible activator activity associ-
ated with  and  were found to be strongly HPN-dependent,
because the addition of small amounts of HPN in the assay
mixtures resulted in sharp enhancement of HPG activation
rates (data not shown); indeed when activator activity of 
domain against substrate HPG was measured after premixing
with HPN, it was found to increase dramatically by several
orders of magnitude compared with its activity measured di-
rectly with HPG. The  domain now exhibited an activity
0.5% that of native SK, whereas the  domain also showed
enhanced activity of approximately 0.05% compared with SK
(Table I, which shows the steady-state kinetic data for HPG
activation). However, it is clear that despite the availability of
preformed HPN as partner, the co-factor activities of both the
single domains remained, at best, a small fraction of that
observed with native nSK.
The presence of relatively low co-factor activities in the iso-
lated domains prompted us to examine whether two-domain
combinations of SK acquired a greater capability for catalysis
as compared with the single-domain constructs. The latter (
and ) were therefore tested for their ability to activate sub-
strate HPG in an HPN-independent or -dependent manner, as
before. It was observed that, as with single-domains,  and 
had very low activities in the absence of HPN (0.05%), as
compared with that of nSK, but in presence of HPN, signifi-
cantly higher catalytic ability as compared with that seen with
individual domains could be observed;  and  had approx-
imately 3.5% and 0.7% co-factor activities in presence of HPN,
respectively, as compared with that of nSK measured under
similar conditions (see also Fig. 2 for comparative HPG activa-
tion progress curves of single- and two-domain constructs). The
steady-state kinetic constants obtained with HPG as substrate
for two-domain constructs are also shown in Table I along with
those of single domains, all activities being measured after
making 1:1 complexes with HPN prior to the assay in presence
of excess substrate HPG. It may also be mentioned that
equimolar mixtures of single domains or mixtures of two or
three domains together did not result in any detectable en-
hancements in activity over those additively associated with
the individual domains, indicating that the covalent contiguity
between the individual domains in  and  contributed syn-
ergistically toward the acquisition of higher activities by the
two-domain construct(s).
An analysis of the steady-state kinetic parameters shown in
Table I indicates that although the two-domain molecules were
minimally altered in Km values for HPG (approximately 0.5 M
in case of nSK), they still exhibited a significantly reduced kcat
for HPG activation when compared with the native protein. In
contrast, we observed a nearly 3–4-fold increase in Km (2 M)
for substrate HPG binding to activator complex in the case of
the single domain, , thereby indicating that the isolated do-
main had probably lesser affinity for substrate HPG in com-
parison with both full-length native nSK and the bi-domain
derivatives. Although these data, together, clearly establish
that there is a dramatic increase in the co-factor capability as
the single domain(s) of SK acquire a two-domain character, the
latter are still significantly compromised in terms of their
catalytic power when compared with the three-domain, native
format.
Interaction of Single and Bi-domain Constructs of SK with
HPG—The inability of single- and bi-domain derivatives of SK
to activate substrate HPG, even with HPN, beyond a certain
low level prompted us to examine their capability (or lack
thereof) to bind HPG. For this purpose, various real time bind-
ing parameters such as association and dissociation rate con-
stants and equilibrium dissociation constants for binary inter-
actions between immobilized biotinylated-HPG and nSK/SK
domains were first determined by the Resonant Mirror ap-
proach using a real time molecular interaction system (IAsys
Ltd.). The kinetic parameters so obtained for the binary inter-
action between immobilized HPG and nSK or those of single- (
and ) and bi-domain constructs ( and ) are shown in
Table II. It is clear from these results that the equilibrium
dissociation constants (KD) of  (2 nM) and  (7.5 nM) are
not grossly different from that of nSK (1.0 nM), whereas the
KD values of single domains (100 nM) are nearly 2 orders of
magnitude greater than that for nSK. These observations in-
dicate that partner HPG binds to the bi-domains with nearly
the same affinity as it binds to nSK, whereas single domains
bind to partner HPG with considerably lesser affinity as com-
pared with native nSK. It is thus possible that the lowered
affinity between the single domain(s) and HPG may be a major
TABLE I
Steady state kinetic parameters for HPG activation by equimolar
complexes of HPN and nSK/SK domains
The kinetic parameters for co-factor activity against HPG as sub-
strate were determined with the respective activator complexes at 22 °C
as described under “Experimental Procedures.” The data represent the
means of three independent determinations.
Activator species Km kcat kcat/Km
M min1 min1 M1
nSKHPN 0.5  0.1 11  0.5 22
HPN 0.6  0.2 0.33  0.1 0.55
HPN 0.6  0.2 0.08  0.02 0.133
HPN 2.0  0.5 0.049  0.02 0.025
HPN NDa 0.005  0.003 ND
a ND, could not be accurately determined because of the intrinsically
low level of co-factor activity.
FIG. 2. Activation of substrate HPG by SK and individual do-
mains of SK. The figure shows progress curves (405 nm versus time2)
for substrate HPG activation by catalytic amounts of activator com-
plexes of nSK or different derivatives of SK complexed with HPN. An
equimolar complex of nSK and HPN (0.5 M each) was prepared over ice
and kept for 1 min, and catalytic amounts of the complex (1 nM, solid
squares; 0.5 nM, open squares) were added to the assay cuvette already
containing HPG (2 M) and chromogenic substrate (0.5 mM). The reac-
tion was then monitored spectrophotometrically at 405 nm over time.
Similarly, an equimolar complex of  and HPN (0.5 M each) was
prepared, and different amounts of the complex (1 nM, solid triangles;
0.5 nM, open triangles) were added into the assay cuvette having chro-
mogenic substrate (0.5 mM) and substrate HPG (2 M). The reaction was
then monitored spectrophotometrically at 405 nm. Substrate HPG ac-
tivation by  domain is also shown. An equimolar mixture with HPN
(0.5 M each) was prepared and incubated on ice for 1 min, following
which varying amounts (1 nM, solid circles; 0.5 nM, open circles) were
then added to the assay cuvette containing HPG (2 M) and chromo-
genic substrate (0.5 mM). All of the reactions were carried out at 25 °C.
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contributive cause to their overall lowered co-factor activity.
However, the native-like affinity observed for HPG in case of
the two-domain constructs, particularly , suggests that the
underlying cause of their lowered co-factor activities does not
likely reside at this level of intermolecular interaction.
After establishing the stability of binary complexes of the
different constructs with immobilized HPG, ternary interac-
tions between “substrate” HPG and different domains of nSK
(single- and bi-domains) precomplexed with immobilized HPG
were explored using, again, an approach based on the Resonant
Mirror technique. The application of the Resonant Mirror tech-
nique for detecting and studying ternary interactions in the
SKHPG system has been reported recently (23). In this direct
approach for analyzing the protein-protein interactions opera-
tive between macromolecular substrate and the SKHPG acti-
vator complex, mildly biotinylated HPG is first immobilized
onto the surface of a Resonant Mirror biotin-cuvette, onto
which a thin film of streptavidin has earlier been layered,
followed by washing with buffer to remove excess unbound
HPG. The immobilized HPG is then “challenged” with SK to
form equimolar SKHPG complex. The binary complex so
formed is washed extensively with buffer, a procedure against
which the high affinity SKHPG binary complex is fairly stable
(23). To the binary complex is then added excess substrate
HPG; the formation of a ternary HPGSKHPG complex can
then be observed to give additional ternary signal over and
above that obtained earlier at the binary complexation stage,
as shown in Fig. 3 (see also Ref. 23). Thus, this assay, which is
capable of monitoring in real time, the “docking” of substrate
HPG onto the preformed SKHPG binary complex can be uti-
lized to explore altered substrate-interacting capability, if pres-
ent, in a SK derivative/mutant after prior complexation with
partner HPG. In the past, we have successfully employed this
approach to demonstrate affinity changes between the SK-
plasmin(ogen) activator complex and its altered form for the
macromolecular substrate, HPG (23). When this assay was
carried out in the present study (see “Experimental Proce-
dures” for details), it was observed that the equilibrium disso-
ciation constant (KD) of the ternary interaction of substrate
HPG with bi-domains of nSK (viz.  and ) was similar to
that of native SK for substrate HPG (0.12 M). The associa-
tion rate constant (ka) and dissociation rate constant (kd) of
ternary interactions between both the bi-domain of nSK and
substrate HPG were found to be nearly similar to that observed
in case of ternary interaction of substrate HPG with native
full-length nSK (Tables I and II). However, in case of the single
domains ( and ), real time kinetic constants for ternary
complexation could not be determined at all essentially because
of the weak nature of binary complex formation, in the first
place, between the isolated domain(s) and immobilized HPG
(Fig. 3C). This was so because, in this case, although the binary
complex(es) could be observed when much higher HPG concen-
trations than those required for nSK were employed, they were
seen to dissociate rapidly even by moderate buffer washing,
conditions under which the native SKHPG was stable. In con-
trast to single domains, however, the results of Resonant Mir-
ror studies on  and  clearly demonstrate that they seem to
be as capable of docking macromolecular substrate as the na-
tive tri-domain nSK molecule.
Taken together, the steady-state kinetics and real time
physico-chemical studies of substrate HPG interaction with
nSK/SK domains clearly establish that although substrate
HPG docks with both the bi-domain derivatives of SK with
nearly the same affinity as that with full-length SK, this near-
native docking of substrate HPG is not proportionately trans-
lated into a nearly native co-factor activity in either of the two
bi-domain derivatives, and the native three-domain structure
is catalytically the most effective in terms of catalytic turnover.
The lack of any significant quantitative co-relation in a given
derivative between the docking ability of substrate on the one
hand and its subsequent catalytic turnover on the other
strongly indicated that these two attributes likely represent
two independent phenomena. Therefore, it appeared probable
that there exist specific interactions between the macromolec-
ular substrate and the SKHPN activator complex at the post-
docking stage that play important role(s) in amplifying the
relative low catalytic power associated with the two-domain
constructs to that associated with the native tri-domain nSK,
ones that are not being effectively utilized by the bi-domains
despite a nearly native ability to dock the macromolecular
substrate. If this were indeed true, one can further extend this
model to assume that these interactions may either be short
range, i.e. localized in and around the scissile peptide bond
region in the catalytic domain of substrate HPG, or they could
be relatively long range, such as those involving the kringle
domains of substrate. Earlier studies on SK have provided a
strong indication that kringle domains of substrate HPG do
play an important role in HPG activation by nSK, because
PG, which is devoid of all the five kringle domains of HPG,
both has significantly lowered affinity for the preformed
SKHPN activator complex (23) and is a poor substrate for
activation (32). Thus, it is conceivable that both catalytic do-
main-centered as well as kringle domain-related interactions
are operative together during substrate recognition and turn-
over by the SKHPN activator complex. Hence, with a view to
obtain insights into the relative contributions of different do-
mains of substrate HPG (i.e. catalytic versus kringle domains),
we compared the rates for activation of HPG by single-, bi-, and
tri-domain structures with those for the isolated catalytic do-
main, using as substrate PG (which also, like native full-
TABLE II
Association and dissociation rate constants and apparent equilibrium dissociation constants of partner
and substrate HPG with SK/SK domains
Kinetic constants for the binary interaction between immobilized biotinylated HPG and nSK/SK domains and thereafter, kinetic constants for
the ternary interaction of substrate HPG with nSK/SK domains were determined as outlined under “Experimental Procedures.” The kinetic
constants were determined by applying the FASTfit™ program to the binding data obtained using IAsys biosensor as described under “Experi-
mental Procedures.” A stable binary complex between nSK/SK domains and HPG immobilized onto the cuvette was made, and then the binding
of varying concentrations of HPG (0.1–1 M) was monitored.
Activator
protein
Binary interaction of SK with partner HPG Ternary interaction of binary complex with substrate HPG
ka kd KD ka kd KD
M
1 s1 s1 M M1 s1 s1 M
nSK 5.8  0.5 107 6.0  0.5102 1.03  0.5109 3  0.4105 3.6  0.3102 0.12  0.05106
 4.8  1.0 107 9.6  1.5102 2.0  0.5109 3.9  0.5105 7.8  1.6102 0.20  0.1 106
 1.46  0.6 107 8.7  1.0102 6.0  1.5109 2.5  1.1105 5.6  1.2102 0.22  0.05106
 0.082  0.05107 9.2  2.0102 112  10 109 NDa ND ND
 0.11  0.03107 9.7  2.0102 87  10 109 ND ND ND
a ND, could not be accurately determined because of the intrinsically low level of co-factor activity.
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length HPG, contains the scissile peptide bond but is devoid of
all the kringle domains).
Interaction of PG with nSK/SK Domains—Microplasmino-
gen was generated from HPG by enzymatic cleavage with plas-
min (see “Experimental Procedures” for details). Kinetic exper-
iments were then performed using PG as substrate and the
different HPN-SK domain(s) as the activator species. The re-
sults demonstrated that in contrast to the activator activity of
native SKHPN with full-length HPG as substrate (taken as
100%), all the three types of SK structures (single-, bi-, and
tri-domain) showed significantly low specific activity, ranging
roughly over 1.0–2% when PG was used as the substrate (see
Table III for steady-state kinetic data). Interestingly, in gen-
eral the Km of nSK/SK domains for PG was seen to be 4–5-fold
lesser than that for full-length HPG, which at least partially
accounts for the generally decreased specific activities observed
when PG was the substrate. However, these low activities
against PG could not be explained merely on the basis of their
lowered affinity for the substrate because even at substrate
saturation the activities of their HPN complexes remained
essentially 40–50-fold lower as compared with that of SKHPN
against full-length HPG (Fig. 4). These results clearly establish
that the co-factor activity of the various constructs against the
kringle-less substrate could not be “compensated” by saturat-
ing the assays with substrate. Thus, the single- and two-do-
main constructs were likely truly compromised not just in
terms of the substrate affinity but in terms of their catalytic
power as well. It is therefore apparent that when kringles are
“lost” from the macromolecular substrate, the catalytic advan-
tage of even the native, three-domain SK becomes compro-
mised, showing that the catalytic domain of macromolecular
substrate is intrinsically a “poor” substrate for the SKHPN
activator complex. Another noticeable feature of the results is
that for both the bi-domain derivatives of SK, the Km for PG
was found to be nearly same as that of SK (2.0 M), whereas
for the  domain there was an2-fold difference in Km for PG
as compared with that of native SK (Tables II and III). This
observation indicates the presence of additional, catalytic do-
main-specific substrate affinity in the two-domain constructs
as compared with the single-domain derivative, . The results
also reveal that with PG as substrate, the catalytic activity of
the bi-domain construct  (although exhibiting the generally
lowered activity of all the constructs, including native SK,
against the kringle-less substrate) was nearly 2-fold lower as
compared with its activity against HPG (Tables I and III). This
suggested that unlike the single domains, the two-domain con-
structs possessed an improved capability to interact with the
kringles of substrate, resulting in a certain degree (although
modest compared with the three-domain design) of catalytic
enhancement, even though other indicators of enzyme-sub-
strate interactions, such as Km for substrate and direct, real
time affinity measurements using Resonant Mirror analyses
did not yield any definitive evidence providing a physico-chem-
ical basis for this functional effect. However, it is clear from the
steady-state kinetic studies that the binary complexes of
nSK/SK domains (i.e. the tri- and bi-domains) interact with
substrate PG with essentially similar Km, although in case of
the  domain, the values are somewhat higher, indicating a
relatively lowered substrate affinity. Remarkably, in all cases,
even at saturating PG concentrations, only poor co-factor
activities compared with that of SKHPN against full-length
HPG were engendered. To directly validate these conclusions,
real time binding parameters of ternary interactions between
PG and nSK/SK domains complexed to immobilized biotinyl-
ated-HPG were determined using the Resonant Mirror tech-
nique. The data (Table III), which are broadly consistent with
the kinetics results, show that equilibrium dissociation con-
stants (KD) of ternary interaction between PG and  (4.0
M) and  (2.0 M) were, at most, minimally different com-
pared with that for nSK (1.0 M). Thus, these analyses sug-
gest that the binary complexes of the bi-domains and the na-
tive, tri-domain nSK with HPG dock PG with affinities that
are not grossly different from each other. However, it is worth
noting that as compared with the docking of substrate HPG
onto the binary complexes of nSK/SK domains, PG docks onto
the latter with an affinity that is approximately an order of
magnitude lower.
One of the main conclusions emerging from the present
study is that kringle domains of HPG play an important role in
docking of the macromolecular substrate onto the native acti-
FIG. 3. Composite pictures of IAsysTM Resonant Mirror-based
real time kinetic analysis to explore the ternary interactions
between substrate HPG and equimolar binary complex of
nSK/SK domains and immobilized HPG. The experiment was car-
ried out at 25 °C in binding buffer as described under “Experimental
Procedures.” Human PG was biotinylated and immobilized on to a layer
of streptavidin captured on the biotin cuvette surface. Stable binary
complexes were then formed by adding saturating concentration of
either nSK (500 nM, A),  (500 nM, B), or  domain (1 M, C) onto the
immobilized HPG. The point of addition of nSK/SK domains (viz. nSK,
A;  domain, B; and  domain, C) in A–C is depicted by arrows 1. After
washing with binding buffer (point of addition of binding buffer de-
picted by arrow 2), a stable dissociation base line (except in case of 
domain, D) was rapidly obtained because of the high affinity and sta-
bility of the binary complexes. Thereafter, various concentrations of
substrate HPG (0.1–1 M) were added onto the binary complexes. How-
ever, for clarity in the figure, only a single (saturating) concentration of
HPG (1 M) is depicted (shown in A and B by arrows 3). The association
phases were monitored for 5 min, and subsequently the cuvettes were
washed with the binding buffer (point of addition depicted in A and B by
arrows 4). After each cycle of analysis in A and B, the undissociated
substrate HPG was stripped off with 2.5 mM EACA, followed by re-
equilibrating the cuvette with binding buffer, which re-established the
original base line (data not shown). The nonspecific binding interaction
between added substrate HPG with the HPG immobilized onto the
cuvette in the absence of any SK/SK derivatives is depicted in D (arrow
1 depicts the addition of binding buffer, arrow 2 depicts the addition of
HPG, and arrow 3 depicts the dissociation of nonspecific HPG with the
binding buffer). Note that the nonspecific signal was found to be less
then 10% of the ternary signal in case of SK/SK derivatives. In a
separate experiment the immobilized streptavidin alone was also taken
as a negative control, and it was subjected to the same kind of treat-
ments as given to the test cell containing immobilized HPG. Under
these conditions no significant nonspecific binding was observed. De-
tailed protocols and rationale for these experiments are provided under
“Experimental Procedures” and in Ref. 23.
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vator complex. However, although the macromolecular docking
phenomenon is crucially important in generating nascent co-
factor activity in the HPN active site, it is probably not the sole
determinant of the “full-blown” co-factor activity associated
with the native system, viz. SKHPN versus HPG as the sub-
strate. This conclusion is supported by the observation that
both the two-domain derivatives,  and , can dock HPG
nearly as efficiently as the native activator complex (as indi-
cated by their respective Km and KD values) but fail to generate
native-like co-factor activity. In other words, the docking of
substrate by the two bi-domain structures is native-like, yet
their catalytic rates are a mere fraction of the rates seen with
native SK and full-length HPG. Thus, it seems reasonable to
conclude that it is only when all three domains of SK simulta-
neously present that the ability to exploit the kringle domains
for improved catalytic rates (as opposed to “mere” improvement
in substrate affinity) effectively gained. Thus, kringles help not
only in docking substrate at the active site but also dramati-
cally accelerate the rates of catalysis by the activator complex.
The present studies strongly suggest that events subsequent to
substrate docking, which require all three domains of native
SK together with the kringle domain(s) of the substrate, are
critical in the development of the full-blown catalytic activity of
the SKHPN activator enzyme, and although stereo-chemical
positioning of the scissile peptide bond is necessary in confer-
ring a native-like macromolecular specificity, it can generate
limited catalytic turnover on its own, with the major jump in
catalytic power being achieved through long range protein-
protein interactions with substrate kringles. This mechanism
of substrate-assisted proteolysis encountered in SK is clearly
distinct from that of other direct HPG activators like tissue
plasminogen activator and urokinase, which display catalysis
with nearly the same rates irrespective of the presence or
absence of kringles in the substrate.2 However, of all these
activators (including SAK), the catalytic power of the SKHPN
complex is recognized to be the highest (18, 34, 42), probably
because of the recruitment of long range interactions between
enzyme and its protein substrate in its catalytic mechanism of
action. This may indeed be the underlying structural reason for
the evolutionary selection of a three-domain activator design,
particularly one in which specific interactions between the
activator species and macromolecular substrate are centered
not only on the target of proteolysis, the catalytic domain
(which, by itself, is not surprising), but also with regions lo-
cated far away from the site of enzymatic action by the active
site per se. Although speculative at present, it seems plausible
that the tri-domain molecule is able to optimally “sense” a
signal during catalysis, probably conformational changes in the
catalytic domain as the scissile peptide bond is cleaved, as well
as the relatively large structural changes that are known to
occur in the orientation of the kringles following the conversion
of substrate plasminogen to plasmin (43, 44). This process, by
facilitating the release of the product of the catalytic cycle from
the active site, would help attain the native-like protein co-
factor activities seen in the SK system. Further detailed stud-
ies are undoubtedly required now to elucidate the exact mech-
2 J. S. Nanda and G. Sahni, unpublished observations.
FIG. 4. Comparison of substrate HPG and PG activation ca-
pability of nSK/SK domains. The histogram depicts the comparison
of co-factor activity of SK, bi-domain constructs of SK ( and ), and
single domain constructs ( and ); in all cases, activity was measured
along with equimolar HPN for the activation of either of two macromo-
lecular substrates, i.e. HPG and PG. The saturating concentration of
HPG used in case of tri- (nSK) and bi-domains ( and ) was 2 M,
whereas in case of single-domains ( and ) the co-factor activity was
measured at 8 M HPG. The co-factor activity of tri- (nSK) and bi-
domains ( and ) was measured at saturating concentration of PG
(4 M), whereas the co-factor activity of single-domains ( and ) was
measured at 10 M PG. The percentage activity of different activator
complexes was then calculated as a percentage value in comparison
with the co-factor activity of SKHPN when HPG was the substrate
taken to be 100%. The histogram shows a maximal percentage of
co-factor activity of different domains of SK against HPG (black) and
PG (light gray) at their respective saturating substrate concentra-
tions. The data highlight the fact that of all the various constructs and
substrate types, only the tri-domain motif was able to generate the full
(100%) activity associated with native SK and full-length HPG,
whereas all the other partial-length constructs with either substrate or
even the native, three-domain SK with PG as substrate were able to
generate only a very low level of co-factor activity compared with
SKHPN and substrate HPG.
TABLE III
Steady state kinetics and real time association-dissociation data for the HPN complex of SK/SK domains with substrate microplasminogen
Kinetic parameters of substrate PG activation were determined at 22 °C spectrophotometrically after mixing with equimolar HPN. Binding
data kinetic constants for substrate PG interactions with nSK/SK domains and immobilized biotinylated HPG were determined by Resonant
Mirror analysis using a IAsys Plus system, as explained under “Experimental Procedures.” A stable binary complex between nSK/SK domains and
immobilized HPG was first made on the reaction cuvette, and then the real time binding isotherms of varying concentrations of PG (1–6 M) were
monitored.
Activator
protein Km kcat kcat/Km ka kd KD
M min1 min1 M1 M1 s1 s1 M
nSK 2.0  0.5 0.26  0.1 0.125 0.3  0.1105 3.3  0.7102 1.1  0.05106
 2.5  0.5 0.22  0.1 0.088 0.67  0.18105 2.7  0.5102 4.07  1.5106
 2.0  0.5 0.20  0.05 0.1 0.13  0.06105 3.7  0.5102 2.3  1.0106
a 4.0  1.0 0.15  0.1 0.0375 NDb ND ND
a ND ND ND ND ND ND
a In case of  and  the binding constants with substrate PG could not be determined as the binary complexes of these isolated domains with
immobilized HPG were intrinsically weak (see Table II) and tended to dissociate rapidly in the binding buffer itself. Thus, reliable estimates of any
ternary complexation even if weak could not be made even at highest concentration of PG (4 M) added.
b ND, not detected.
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anisms, for example those exploiting site-specific spectroscopic
monitoring for fluorescence resonance energy transfer analysis
to help probe the molecular motions during substrate capture,
catalytic transformation, and, finally, product release. How-
ever, the results presented in this study, by illuminating the
initial steps in an otherwise extremely complex biochemical
reaction, unambiguously indicate that the substrate-specific
proteolytic capability generated in the immediate vicinity of
the HPN active site upon complexation with SK is amplified in
a dramatic manner through long range, “supra-catalytic cen-
ter-based” protein-protein interactions between the co-factor
and macromolecular substrate. The elucidation of the exact
molecular events and epitopes involved in this process would
greatly help in the redesign of existing proteases into efficient
substrate specific HPG activator enzymes and also in the fu-
ture de novo design of novel target-specific proteolytic function-
alities with useful applicability.
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